NanoString NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project The partners will use NanoString's nCounter and CAR-T Characterization Panel to ID molecular features that make CAR T-cell therapies more effective. GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. NanoString Technologies Q1 Revenues Grow 19 Percent The firm's product and service revenues grew 28 percent year over year to $31.4 million, but collaboration revenues fell to just $223,000 from $2.1 million. NanoString Technologies Q4 Revenues Fall 2 Percent The Seattle-based firm saw collaboration revenues fall 83 percent from Q4 2019 and 73 percent from full-year 2019. JP Morgan Healthcare Conference 2021, Day 3: Exact Sciences, Danaher, NanoString, Bio-Techne, More Exact Sciences discussed new Cologuard data; Danaher reviewed Cepheid's 2020 performance; and NanoString talked about forthcoming spatial biology products. Jan 11, 2021 NanoString Technologies Expects Q4 Product and Service Revenues to Climb 6 Percent Jan 4, 2021 GenomeWeb Index Ends 2020 on Upswing With Pacific Biosciences in Lead Dec 30, 2020 Spatial Biology Interest, Products Mushroomed in 2020 Premium Dec 2, 2020 NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022 Premium Nov 17, 2020 NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development Nov 13, 2020 New Products Posted to GenomeWeb: Illumina, NanoString Technologies, New England Biolabs, More Nov 9, 2020 NanoString Q3 Revenues Grow 4 Percent Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 8, 2020 NanoString Technologies Prices $200M Public Offering Oct 7, 2020 NanoString Technologies Q3 Preliminary Product, Service Revenues Grow 14 Percent Aug 11, 2020 NanoString Launches NGS Readout for Spatial Transcriptomics, Partners With Illumina on Informatics Premium Aug 10, 2020 NanoString Technologies Q2 Revenues Drop 25 Percent But Beat Street Estimates May 20, 2020 NanoString, OnRamp to Create Cloud-Based Analysis Tools for nCounter Data May 7, 2020 NanoString Q1 Revenues Shrink 4 Percent but Beat Wall Street Expectations on Top Line Apr 23, 2020 Veracyte Licenses Lung Disease Genomic Classifier From Yale University Apr 7, 2020 NanoString Preliminary Q1 Revenues Take Hit From COVID-19, Firm Withdraws 2020 Guidance Apr 1, 2020 Coronavirus Fears Run Rampant Through Stock Market as Indices Tumble Mar 5, 2020 NanoString Prices Upsized $200 Million Senior Notes Offering Mar 4, 2020 NanoString Technologies Proposes Private Offering of $175M in Convertible Senior Notes Mar 2, 2020 Amid Terrible End of Month for Stock Market, GenomeWeb Index Drops 7 Percent in February Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.